Ishikawa, E., Miyazaki, T., Matsuda, M., Takano, S., & Matsumura, A. (2019). IM-01 PI3K GAMMA INHIBITOR FOR OVERCOMING TREATMENT RESISTANCE IN COMBINATION THERAPY OF TEMOZOLOMIDE AND ANTI-PDL1 ANTIBODY FOR GLIOBLASTOMA PATIENTS. Neurooncol Adv.
Trích dẫn kiểu ChicagoIshikawa, Eiichi, Tsubasa Miyazaki, Masahide Matsuda, Shingo Takano, và Akira Matsumura. "IM-01 PI3K GAMMA INHIBITOR FOR OVERCOMING TREATMENT RESISTANCE IN COMBINATION THERAPY OF TEMOZOLOMIDE AND ANTI-PDL1 ANTIBODY FOR GLIOBLASTOMA PATIENTS." Neurooncol Adv 2019.
Trích dẫn MLAIshikawa, Eiichi, et al. "IM-01 PI3K GAMMA INHIBITOR FOR OVERCOMING TREATMENT RESISTANCE IN COMBINATION THERAPY OF TEMOZOLOMIDE AND ANTI-PDL1 ANTIBODY FOR GLIOBLASTOMA PATIENTS." Neurooncol Adv 2019.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.